Tofacitinib 5mg tablets
NHS hospitals in England used £20,185,470 of indicative cost of Tofacitinib 5mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 1.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Tofacitinib 5mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Tofacitinib 5mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Lancashire Care Nhs Foundation Trust | £1,270,833 |
| Royal Devon & Exeter Nhs Foundation Trst | £552,626 |
| Norfolk & Norwich University Hpl Nhs Trt | £402,913 |
| Guy's & St Thomas' Nhs Foundation Trust | £384,975 |
| Royal Cornwall Hospitals Nhs Trust | £375,316 |
| Derby Teaching Hospitals Nhs Found Trust | £362,898 |
| Royal Free London Nhs Foundation Trust | £360,188 |
| Cambridge Univ Hosp Nhs Foundation Trust | £359,448 |
| University College London Foundation Tr | £335,991 |
| Sheffield Teaching Hospitals Nhs Trust | £333,921 |
The primary-care picture
Tofacitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Tofacitinib medicine page.